Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Medtronic
Cerilliant
Moodys
McKinsey
Deloitte
Covington
Accenture

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200890

« Back to Dashboard

NDA 200890 describes ISOPTO CARPINE, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from three suppliers. Additional details are available on the ISOPTO CARPINE profile page.

The generic ingredient in ISOPTO CARPINE is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
Summary for 200890
Tradename:ISOPTO CARPINE
Applicant:Novartis Pharms Corp
Ingredient:pilocarpine hydrochloride
Patents:0
Therapeutic Class:Dental and Oral Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 200890
Suppliers and Packaging for NDA: 200890
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ISOPTO CARPINE pilocarpine hydrochloride SOLUTION;OPHTHALMIC 200890 NDA Alcon Laboratories, Inc. 0998-0203 N 0998-0203-15
ISOPTO CARPINE pilocarpine hydrochloride SOLUTION;OPHTHALMIC 200890 NDA Alcon Laboratories, Inc. 0998-0204 N 0998-0204-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;OPHTHALMICStrength1%
Approval Date:Jun 22, 2010TE:ATRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;OPHTHALMICStrength2%
Approval Date:Jun 22, 2010TE:ATRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;OPHTHALMICStrength4%
Approval Date:Jun 22, 2010TE:ATRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fuji
AstraZeneca
Julphar
Queensland Health
Moodys
Medtronic
US Department of Justice
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.